{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:14:12Z","timestamp":1754108052037,"version":"3.37.3"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T00:00:00Z","timestamp":1555286400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1038\/s41409-019-0530-4","type":"journal-article","created":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T18:05:04Z","timestamp":1555351504000},"page":"260-264","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Transmission of chromosomally integrated human herpes virus-6A via haploidentical stem cell transplantation poses a risk for virus reactivation and associated complications"],"prefix":"10.1038","volume":"55","author":[{"given":"Lena","family":"Oevermann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2956-1410","authenticated-orcid":false,"given":"Cosima","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1544-9903","authenticated-orcid":false,"given":"Sebastian","family":"Voigt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"K\u00fcnkele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5398-0610","authenticated-orcid":false,"given":"Stephan","family":"Lobitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelika","family":"Eggert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes H.","family":"Schulte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedikt B.","family":"Kaufer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hedwig E.","family":"Deubzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,15]]},"reference":[{"key":"530_CR1","unstructured":"AWMF. AWMF-\u00adLeitlinie 025\/016: Sichelzellkrankheit. In: AWMF: Cario, Holger; Grosse, Regine; Jarisch, Andrea; Lobitz, Stephan; Kulozik, Andreas; Kunz, Joachim, 2014."},{"key":"530_CR2","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/bmt.2017.49","volume":"52","author":"J Foell","year":"2017","unstructured":"Foell J, Pfirstinger B, Rehe K, Wolff D, Holler E, Corbacioglu S. Haploidentical stem cell transplantation with CD3(+)-\/CD19(+)- depleted peripheral stem cells for patients with advanced stage sickle cell disease and no alternative donor: results of a pilot study. Bone Marrow Transpl. 2017;52:938\u201340. \nhttps:\/\/doi.org\/10.1038\/bmt.2017.49","journal-title":"Bone Marrow Transpl"},{"key":"530_CR3","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1182\/blood-2012-07-438408","volume":"120","author":"J Bolanos-Meade","year":"2012","unstructured":"Bolanos-Meade J, Fuchs EJ, Luznik L, Lanzkron SM, Gamper CJ, Jones RJ, et al. HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease. Blood. 2012;120:4285\u201391. \nhttps:\/\/doi.org\/10.1182\/blood-2012-07-438408","journal-title":"Blood"},{"key":"530_CR4","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1093\/jpids\/piy111","volume":"7","author":"DM Zerr","year":"2018","unstructured":"Zerr DM. Human herpesvirus 6B in the transplant recipient: when to worry, when to act. J Pediatr Infect Dis Soc. 2018;7:S75\u2013S78. \nhttps:\/\/doi.org\/10.1093\/jpids\/piy111\n\n. Review","journal-title":"J Pediatr Infect Dis Soc"},{"key":"530_CR5","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1016\/j.bbmt.2016.09.018","volume":"22","author":"R Greco","year":"2016","unstructured":"Greco R, Crucitti L, Noviello M, Racca S, Mannina D, Forcina A, et al. Human herpesvirus 6 infection following haploidentical transplantation: immune recovery and outcome. Biol Blood Marrow Transpl. 2016;22:2250\u20135. \nhttps:\/\/doi.org\/10.1016\/j.bbmt.2016.09.018","journal-title":"Biol Blood Marrow Transpl"},{"key":"530_CR6","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00705-013-1902-5","volume":"159","author":"D Ablashi","year":"2014","unstructured":"Ablashi D, Agut H, Alvarez-Lafuente R, Clark DA, Dewhurst S, DiLuca D, et al. Classification of HHV-6A and HHV-6B as distinct viruses. Arch Virol. 2014;159:863\u201370. \nhttps:\/\/doi.org\/10.1007\/s00705-013-1902-5","journal-title":"Arch Virol"},{"key":"530_CR7","doi-asserted-by":"crossref","first-page":"8040","DOI":"10.1128\/JVI.73.10.8040-8052.1999","volume":"73","author":"G Dominguez","year":"1999","unstructured":"Dominguez G, Dambaugh TR, Stamey FR, Dewhurst S, Inoue N, Pellett PE. Human herpesvirus 6B genome sequence: coding content and comparison with human herpesvirus 6A. J Virol. 1999;73:8040\u201352.","journal-title":"J Virol"},{"key":"530_CR8","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1056\/NEJM199408183310703","volume":"331","author":"CB Hall","year":"1994","unstructured":"Hall CB, Long CE, Schnabel KC, Caserta MT, McIntyre KM, Costanzo MA, et al. Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. N Engl J Med. 1994;331:432\u20138. \nhttps:\/\/doi.org\/10.1056\/NEJM199408183310703","journal-title":"N Engl J Med"},{"key":"530_CR9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1146\/annurev-virology-031413-085422","volume":"1","author":"N Osterrieder","year":"2014","unstructured":"Osterrieder N, Wallaschek N, Kaufer BB. Herpesvirus genome integration into telomeric repeats of host cell chromosomes. Annu Rev Virol. 2014;1:215\u201335. \nhttps:\/\/doi.org\/10.1146\/annurev-virology-031413-085422","journal-title":"Annu Rev Virol"},{"key":"530_CR10","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/cid\/ciu323","volume":"59","author":"A Endo","year":"2014","unstructured":"Endo A, Watanabe K, Ohye T, Suzuki K, Matsubara T, Shimizu N, et al. Molecular and virological evidence of viral activation from chromosomally integrated human herpesvirus 6A in a patient with X-linked severe combined immunodeficiency. Clin Infect Dis. 2014;59:545\u20138. \nhttps:\/\/doi.org\/10.1093\/cid\/ciu323","journal-title":"Clin Infect Dis"},{"issue":"2","key":"530_CR11","doi-asserted-by":"publisher","first-page":"e13084","DOI":"10.1111\/petr.13084","volume":"22","author":"Lena E. Winestone","year":"2017","unstructured":"Winestone LE, Punn R, Tamaresis JS, Buckingham J, Pinsky BA, Waggoner JJ, et al. High human herpesvirus 6 viral load in pediatric allogeneic hematopoietic stem cell transplant patients is associated with detection in end organs and high mortality. Pediatr Transplant. 2018;22. \nhttps:\/\/doi.org\/10.1111\/petr.13084.","journal-title":"Pediatric Transplantation"},{"key":"530_CR12","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1016\/j.bbmt.2018.04.021","volume":"24","author":"TL Phan","year":"2018","unstructured":"Phan TL, Carlin K, Ljungman P, Politikos I, Boussiotis V, Boeckh M, et al. Human herpesvirus-6B reactivation is a risk factor for grades II to IV acute graft-versus-host disease after hematopoietic stem cell transplantation: a systematic review and meta-analysis. Biol Blood Marrow Transpl. 2018;24:2324\u201336. \nhttps:\/\/doi.org\/10.1016\/j.bbmt.2018.04.021","journal-title":"Biol Blood Marrow Transpl"},{"key":"530_CR13","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1038\/bmt.2015.76.","volume":"50","author":"M Ogata","year":"2015","unstructured":"Ogata M, Fukada T, Teshima T. Human herpesvirus-6 encephalitis after allogeneic hematopoietic cell transplantation: what we do and do not know. Bone Marrow Transpl. 2015;50:1030\u20136. \nhttps:\/\/doi.org\/10.1038\/bmt.2015.76.","journal-title":"Bone Marrow Transpl"},{"key":"530_CR14","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1111\/ajt.14657","volume":"18","author":"P Bonnafous","year":"2018","unstructured":"Bonnafous P, Marlet J, Bouvet D, Salame E, Tellier AC, Guyetant S, et al. Fatal outcome after reactivation of inherited chromosomally integrated HHV-6A (iciHHV-6A) transmitted through liver transplantation. Am J Transpl. 2018;18:1548\u201351. \nhttps:\/\/doi.org\/10.1111\/ajt.14657","journal-title":"Am J Transpl"},{"key":"530_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.coviro.2014.09.019","volume":"9","author":"MN Prichard","year":"2014","unstructured":"Prichard MN, Whitley RJ. The development of new therapies for human herpesvirus 6. Curr Opin Virol. 2014;9:148\u201353. \nhttps:\/\/doi.org\/10.1016\/j.coviro.2014.09.019","journal-title":"Curr Opin Virol"},{"key":"530_CR16","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1200\/JCO.2017.73.0655","volume":"35","author":"I Tzannou","year":"2017","unstructured":"Tzannou I, Papadopoulou A, Naik S, Leung K, Martinez CA, Ramos CA, et al. Off-the-shelf virus-specific T cells to treat BK virus, human herpesvirus 6, cytomegalovirus, Epstein-Barr virus, and adenovirus infections after allogeneic hematopoietic stem-cell transplantation. J Clin Oncol. 2017;35:3547\u201357. \nhttps:\/\/doi.org\/10.1200\/JCO.2017.73.0655","journal-title":"J Clin Oncol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0530-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0530-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0530-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:14:34Z","timestamp":1684617274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-019-0530-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,15]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["530"],"URL":"https:\/\/doi.org\/10.1038\/s41409-019-0530-4","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"type":"print","value":"0268-3369"},{"type":"electronic","value":"1476-5365"}],"subject":[],"published":{"date-parts":[[2019,4,15]]},"assertion":[{"value":"16 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}